HOME Study: a Combination Support Package to Increase Uptake of PrEP and HIV/STI Testing
NCT ID: NCT03138135
Last Updated: 2021-04-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
104 participants
INTERVENTIONAL
2017-01-09
2018-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
We will also evaluate whether the online tools help these men to connect with HIV prevention services such as Pre-Exposure Prophylaxis (PrEP) if they test HIV negative, and to HIV care services if they test HIV positive.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pre-exposure Prophylaxis (PrEP) at Home
NCT03569813
Evaluating a Real-Time, Remote Monitoring System for Home-Based HIV Testing
NCT02876926
Implementation of Rapid HIV Self-Testing Among MSM Project
NCT04219878
Facilitating HIV Testing Among Young Adult MSM Through Social Networking
NCT02369627
Evaluation of Rapid HIV Self-testing Among MSM (eSTAMP)
NCT02067039
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
The Intervention group will receive the HOME Study intervention.
HOME Study intervention
Access to home HIV test kits, home STI self-collection kits, the HOME Study website, and the SexPro HIV risk assessment tool.
Control
The Control group will receive standard of care.
Control
Counseling about the importance of quarterly HIV/STI testing and a PrEP information pamphlet.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HOME Study intervention
Access to home HIV test kits, home STI self-collection kits, the HOME Study website, and the SexPro HIV risk assessment tool.
Control
Counseling about the importance of quarterly HIV/STI testing and a PrEP information pamphlet.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Report anal sex with at least one male sex partner in the prior 12 months.
* HIV negative by self-report.
* Currently own a cell phone.
* Willing and able to provide written informed consent.
Exclusion Criteria
* In a mutually monogamous sexual relationship for the past 12 months.
* Currently taking PrEP.
* Does not have reliable access to the Internet.
* Does not live, work, or play in the San Francisco Bay Area.
* Planning to move out of the Bay Area during the 9 month study period.
* Previously participated in the HOME Pilot study.
* Any medical, psychiatric, or social condition, or occupational, or other responsibility that, in the judgment of the investigator, would make participation in the study unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives.
18 Years
35 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
San Francisco Department of Public Health
OTHER_GOV
University of California, San Francisco
OTHER
Public Health Foundation Enterprises, Inc.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Susan Buchbinder
Director, Bridge HIV
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hyman Scott, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Public Health Foundation Enterprises; San Francisco Department of Public Health
Susan Buchbinder, MD
Role: PRINCIPAL_INVESTIGATOR
Public Health Foundation Enterprises; San Francisco Department of Public Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bridge HIV, San Francisco Department of Public Health
San Francisco, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Bridge HIV Health Equity Studies homepage
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16-20492
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.